A recent report by The Lancet Child & Adolescent Health Commission highlights the urgent need for improved newborn care to address the “unacceptably high” global death rate among infants. The study, involving experts like Professors Peter Davis and David Tingay from the Murdoch Children’s Research Institute (MCRI), calls for stronger leadership, collaboration, and innovation in neonatology to enhance survival and long-term health outcomes for newborns.
The report reveals that 2.3 million children died within their first 28 days of life in 2022, accounting for 47% of all deaths in children under five. Despite progress in neonatal medicine over the past 25 years, significant challenges persist, including inadequate drug and medical device development, off-label medication use, and a lack of evidence-based treatments.
Professor Davis emphasized that current platforms for neonatal care are insufficient, particularly for preterm or critically ill infants. “The perception of newborn health research as unimportant, excessive bureaucracy, and a global shortage of expertise are major barriers,”he said. The report also underscores the need for better collaboration among healthcare professionals, families, and advocacy groups to drive meaningful change.
Professor Davis added, “When babies receive the best start in life, it boosts a country’s productivity, resilience, and future prosperity.” He stressed the importance of addressing these challenges through coordinated efforts involving ethics committees, regulators, and governments.
The Lancet Commission’s findings serve as a roadmap to accelerate research and innovation in neonatology. By prioritizing newborn health, the global community can reduce preventable deaths and ensure healthier futures for generations to come.
Add comment